The drug from the common cold :: Consumers survey results of 2015

Consumers survey results of 2015 in category

Cold and Flu / The drug from the common cold

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Нокспрей (Сперко Україна)	30.53%	5

2.		Піносол (Zentiva)	18.32%	3.38

3.	8	Назол (Bayer)	17.56%	3.23

4.	5	Aqua Maris (Jadran)	15.27%	3.08

5.	14	Синупрет (Bionorica)	14.50%	2.50

6.	13	Фармазолін (Farmak)	12.21%	2.18

7.	6	Делуфен (Perrigo)	10.69%	2.00

8.	15	Nasivin (Dr. Reddy’s)	9.92%	1.88

9.	4	Віброцил (Novartis OTC)	9.92%	1.75

10.	23	Евказолін Аква (Farmak)	9.16%	1.65

11.	25	Риназолін (Farmak)	8.40%	1.53

12.	10	Нафтизин (Farmak)	7.63%	1.43

13.	12	IRS 19 (Abbott Laboratories)	7.63%	1.35

14.	11	Отривін (Novartis OTC)	6.87%	1.33

15.	17	Lazorin (Boehringer Ingelheim)	7.63%	1.23

16.	3	Санорин (Teva)	4.58%	1.10

17.	9	Хьюмер (Delta Medical)	6.11%	1.05

18.	17	Цинабсин (DHU)	4.58%	0.95

19.	~	Каметон (Стома)	4.58%	0.80

20.	7	Галазолін (ICN Polfa Rzeszow)	3.05%	0.75

21.		Rint (Farmak)	3.82%	0.70

21.	~	Мілістан Сінус (Mili Healthcare)	3.82%	0.70

21.	~	Назалонг (Валартін Фарма)	3.82%	0.70

24.	19	Назолін-Дарниця (Darnitsa)	3.05%	0.60

25.	20	Но-соль (Farmak)	2.29%	0.48

26.		Грипостад Ріно (Nizhpharm)	2.29%	0.45

27.	20	Спрей назальний др. Тайсс (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	3.05%	0.40

28.	~	Аллертек (ICN Polfa Rzeszow)	1.53%	0.35

29.	22	Tyzine (Johnson & Johnson)	1.53%	0.25

29.	18	Асініс (Perrigo)	1.53%	0.25

31.	26	Ксимелін Екстра (Takeda)	1.53%	0.23

32.	~	Quixx (Berlin-Chemie Menarini)	1.53%	0.20

33.	~	Риностоп (Bosnalijek)	0.76%	0.13

34.	16	Длянос (Novartis OTC)	0.76%	0.10

34.	24	Маример (Acino Pharma AG)	0.76%	0.10

34.	27	Ноксивін (Фармтехнологія)	0.76%	0.10

–.		Гайморин (Національна гомеопатична спілка)	0.00%	0

–.	24	Ксилометазолін (ICN Polfa Rzeszow)	0.00%	0

–.		Піновіт (Farmak)	0.00%	0

–.		Ріназал (Darnitsa)	0.00%	0

–.		СНУП (Stada)	0.00%	0

–.		Синус-ліфт Актив (Georg BioSystems)	0.00%	0

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2015, recommendation of consumers #1 in the category “The drug from the common cold”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2015, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.